References

• Bernard, K.A. & Kramer, L.D.  (2001, November 4).  Review West Nile Virus activity in the United States, 2001.  Viral Immunology 14 (4): 319:338.
• United States Centers for Disease Control & Prevention.  (2002).  West Nile Virus, 2002:  Southern and Western Expansion.
• United States Centers for Disease Control & Prevention. (2003, September 17). West Nile Virus 2002 Case Count.  CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 23, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount2002.htm
• United States Centers for Disease Control & Prevention. (2004, May 21). 2003 West Nile Virus activity in the United States.  CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 23, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount03_detailed.htm
• United States Centers for Disease Control & Prevention. (2005, June 22). 2004 West Nile Virus activity in the United States.  CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 23, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCaseCount04_detailed.htm
• United States Centers for Disease Control & Prevention.  (2003, July 2).  West Nile Virus:  Ecology & virology.  CDC:  Division of Vector-Borne Infectious Diseases.  Retrieved July 23, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/ecology.htm
• West Nile virus:  Molecular actions of the West Nile virus. [Undated].  University of Minnesota Environmental & Occupational Health.  Retrieved July 23, 2005, from http://www1.umn.edu/eoh/hazards/hazardssite/westnilevirus/molaction.html
• Centers for Disease Control & Prevention.  (2004, September 29). West Nile virus:  Information and guidance for clinicians. CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 24, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/
• Macedo de Oliveira, A., Beecham, B.D., Montgomery, S.P. et al.  (2004, December).  West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 44: 1695-1699.
• United States Centers for Disease Control & Prevention.  (2004, April 9).  Update:  West Nile virus screening of blood donations and transfusion-associated transmission—United States, 2003.  MMWR 53 (13): 281-284.  Retrieved July 24, 2005, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5313a1.htm
• United States Centers for Disease Control & Prevention.  (2003, September 18).  Update:  Detection of West Nile virus in blood donations—United States, 2003.  MMWR 52 (Dispatch): 1-3.  Retrieved July 24, 2005, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm52d918a1.htm
• Gelfand, M.S.  (2003, July). West Nile virus.  Postgraduate Medicine Online.  Retrieved July 25, 2005, from http://www.postgradmed.com/issues/2003/07_03/gelfand.htm
• A special announcement from HRSA regarding West Nile virus.  (2004, January 9).  The Organ Procurement and Transplantation Network.  Retrieved July 25, 2005, from http://www.optn.org/news/newsDetail.asp?id=303
• US Department of Health & Human Services grants orphan drug designation of immune globulin (human) containing high titers of West Nile virus antibodies for the treatment of the West Nile virus Infection: Omr-IgG-am.  (2004, May 17). OMRIX.  Retrieved July 25, 2005, from http://www.omrix.com/home.html
• NIAID expands West Nile virus treatment trial.  (2004, July 12).  [Press Release.]  NIH News, National Institutes of Health. OMRIX.  Retrieved July 25, 2005, from http://www.omrix.com/home.html
• United States Centers for Disease Control & Prevention. (2004, September 9).  West Nile virus:  Questions and answers. . CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 24, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/q&a.htm
• United States Centers for Disease Control & Prevention. (2002, December 20).  Intrauterine West Nile virus infection—New York, 2002.  MMWR 51 (50):  1135-1136.  Retrieved July 25, 2005, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5150a3.htm
• O’Leary, D.  (2004, February).  West Nile Virus Disease in Pregnancy.  [PowerPoint]. CDC:  Division of Vector-Borne Infectious Diseases.   Downloaded July 24, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/conf/February_2004.htm
•  United States Centers for Disease Control & Prevention. (2002, October 4). Possible West Nile virus transmission to an infant through breast-feeding—Michigan, 2002.  MMWR.  51(39): 877-878.  Retrieved July 25, 2005, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5139a1.htm
• United States Centers for Disease Control & Prevention. (2002, December 20). Laboratory-acquired West Nile virus infections---United States, 2002.  MMWR.  51(50): 1133-1135.  Retrieved July 25, 2005, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5150a2.htm
• Campbell, G.L., Marfin, A.A., Lanciotti, R.S. & Gubler, D.J. (2002, September). Reveiws:  West Nile virus.   The Lancet 2: 519-529.
• Gorsche, R., & Tilley, P.  (2005, May 24). The rash of West Nile virus infection.  CMAJ 172 (11): 1440.  Retrieved July 24, 2005, from http://www.cmaj.ca/cgi/content/full/172/11/1440
• Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Ewing D, Mazowiecki M, et al. West Nile virus–associated flaccid paralysis. Emerg Infect Dis [serial on the Internet]. 2005 Jul [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol11no07/04-0991.htm
• United States Centers for Disease Control and Prevention.  (2005, June 29).  Recommendations to protect outdoor workers from West Nile virus exposure.  National Institude for Occupational Safety and Health.  Retrieved July 26, 2005, from http://www.cdc.gov/niosh/topics/westnile/recout.html
• United States Centers for Disease Control and Prevention.  (2005, June 29).  Recommendations to protect laboratory, field, and clinical workers from West Nile virus exposure.  National Institude for Occupational Safety and Health.  Revised July 27, 2006 http://www.cdc.gov/niosh/topics/westnile/reclab.html
• Bren, L.  (2003, November).  West Nile virus:  Reducing the risk.  U.S. Food and Drug Administration.  Retrieved July 26, 2005, from http://www.fda.gov/fdac/features/2003/103_virus.html
• United States Centers for Disease Control & Prevention.  (2005, April 22). Updated information regarding insect repellents. CDC:  Division of Vector-Borne Infectious Diseases.   Retrieved July 26, 2005, from http://www.cdc.gov/ncidod/dvbid/westnile/RepellentUpdates.htm
• Pesticides and mosquito control.  (2002, April 17).  U.S. Environmental Protection Agency.  Retrieved July 26, 2005, from http://www.epa.gov/pesticides/factsheets/pesticides4mosquitos.htm
• NIAID research on West Nile virus.  (2005, April).  National Institute of Allergy & Infectious Diseases.  Retreived July 26, 2005, from http://www.niaid.nih.gov/factsheets/westnile.htm
• Watson, J.T., Pertel, P.E., Jones, R.C., et al.  (2004, September 7).  Clinical characteristics and functional outcomes of West Nile Fever. Annals of Internal Medicine 141: 260-365.
• Jeha, L, & Sila, C.A. (2004, January 23).  Neurological complications of West Nile virus.  Cleveland Clinic.  Retrieved July 26, 2005, from http://www.clevelandclinicmeded.com/diseasemanagement/neurology/wnv_neuro/wnv_neuro.htm
• M. Hunt, (2006, October 25). Interferon. Microbiology and Immunology Online. University of South Carolina School of Medicine.
  http://pathmicro.med.sc.edu/mhunt/interferon.htm
• The Host Response to West Nile Virus Infection Limits Viral Spread through the Activation of the Interferon Regulatory Factor 3 Pathway. Fredericksen BL, Smith M, Katze MG, Shi PY, Gale M Jr. J Virol. (2004) Jul; 78(14): 7737-7747.
• M. Hunt. (2004) BASIC VIROLOGY: REPLICATION OF VIRUSES. Microbiology Online. University of South Carolina
  http://pathmicro.med.sc.edu/mhunt/replicat.htm
• AVI BioPharma. (2004) AVI BioPharma Announces Initiation of Acute West Nile Virus Clinical Study. http://www.avibio.com/pr/pr234.html
• Nasci RS, Savage HM, White DJ, Miller JR, Cropp BC, Godsey MS, Kerst AJ, Bennett P, Gottfried K, Lanciotti RS. West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis. 2001 Jul-Aug;7(4):742-4
• Thomas P. Monath, Jian Liu, (2006) A live, attenuated recombinant West Nile virus vaccine. Proceedings of the National Academy of Sciences of the United States of America. April 14, 2006, 10.1073/pnas.0601932103
• Reisen WK, Takahashi RM, Carroll BD, Quiring R. Delinquent mortgages, neglected swimming pools, and West Nile virus, California. Emerg Infect Dis [serial on the Internet]. 2008 Nov [date cited]. Available from http://www.cdc.gov/EID/content/14/11/1747.htm